다한증 치료 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Hyperhidrosis Treatment Market size is expected to reach USD 1242.97 Million in 2034 from USD 765.08 Million (2025) growing at a CAGR of 5.54% during 2026-2034.

The global hyperhidrosis treatment market is experiencing growing demand as awareness about excessive sweating disorders increases. Hyperhidrosis affects millions of individuals worldwide and can significantly impact quality of life and confidence. Treatment options include topical medications, oral drugs, botulinum toxin injections, and advanced procedures such as microwave therapy and surgical interventions.

Rising awareness about available treatment options and increasing diagnosis rates are key drivers of market growth. Healthcare providers are adopting modern therapeutic solutions that provide longer-lasting relief from excessive sweating. In addition, aesthetic and dermatology clinics are offering specialized treatments for hyperhidrosis, contributing to expanding market adoption.

The future outlook for the hyperhidrosis treatment market remains positive as medical research continues to develop more effective therapies. Growing interest in minimally invasive procedures and dermatological treatments will likely drive demand. As healthcare access improves and awareness increases, more patients are expected to seek treatment for this condition.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Axillary Hyperhidrosis
• Palmar Hyperhidrosis
• Plantar Hyperhidrosis
• Other Types

By Treatment

• Topical Treatment
• Oral Medication
• Botulinum Toxin Injections
• Iontophoresis
• Surgical Treatment

By Age

• Below 50 years
• Above 50 years

By End-user

• Hospitals
• Ambulatory Surgical Centers
• Dermatology Clinics
• Other End-Users

COMPANIES PROFILED

• AbbVie Inc, Avanor Healthcare Ltd, Brickell Biotech Inc, Dermadry Laboratories Inc, Dermavant Sciences Inc, Hugel Inc, Eirion Therapeutics Inc, Eli Lilly and Company, Intas Pharmaceuticals Ltd, Kaken Pharmaceutical Co Ltd, Maruho Co Ltd, miraDry Inc, SweatBlock
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HYPERHIDROSIS TREATMENT MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Axillary Hyperhidrosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Palmar Hyperhidrosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Plantar Hyperhidrosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Other Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HYPERHIDROSIS TREATMENT MARKET: BY TREATMENT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Treatment
• 5.2. Topical Treatment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Oral Medication Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Botulinum Toxin Injections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Iontophoresis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Surgical Treatment Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HYPERHIDROSIS TREATMENT MARKET: BY AGE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Age
• 6.2. Below 50 years Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Above 50 years Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HYPERHIDROSIS TREATMENT MARKET: BY END-USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-user
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Dermatology Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Other End-Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL HYPERHIDROSIS TREATMENT MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Type
  • 8.2.2 By Treatment
  • 8.2.3 By Age
  • 8.2.4 By End-user
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Type
  • 8.3.2 By Treatment
  • 8.3.3 By Age
  • 8.3.4 By End-user
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Type
  • 8.4.2 By Treatment
  • 8.4.3 By Age
  • 8.4.4 By End-user
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Type
  • 8.5.2 By Treatment
  • 8.5.3 By Age
  • 8.5.4 By End-user
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Type
  • 8.6.2 By Treatment
  • 8.6.3 By Age
  • 8.6.4 By End-user
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL HYPERHIDROSIS TREATMENT INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 AbbVie Inc
  • 10.2.2 Avanor Healthcare Ltd
  • 10.2.3 Brickell Biotech Inc
  • 10.2.4 Dermadry Laboratories Inc
  • 10.2.5 Dermavant Sciences Inc
  • 10.2.6 Hugel Inc
  • 10.2.7 Eirion Therapeutics Inc
  • 10.2.8 Eli Lilly And Company
  • 10.2.9 Intas Pharmaceuticals Ltd
  • 10.2.10 Kaken Pharmaceutical Co. Ltd
  • 10.2.11 Maruho Co. Ltd
  • 10.2.12 MiraDry Inc
  • 10.2.13 SweatBlock